Literature DB >> 27225618

[Formula: see text]Working memory and attention in pediatric brain tumor patients treated with and without radiation therapy.

Kimberly P Raghubar1, E Mark Mahone2, Keith Owen Yeates3, Kim M Cecil4, Monwabisi Makola4, M Douglas Ris1.   

Abstract

Children are at risk for cognitive difficulties following the diagnosis and treatment of a brain tumor. Longitudinal studies have consistently demonstrated declines on measures of intellectual functioning, and recently it has been proposed that specific neurocognitive processes underlie these changes, including working memory, processing speed, and attention. However, a fine-grained examination of the affected neurocognitive processes is required to inform intervention efforts. Radiation therapy (RT) impacts white matter integrity, likely affecting those cognitive processes supported by distributed neural networks. This study examined working memory and attention in children during the early delayed stages of recovery following surgical resection and RT. The participants included 27 children diagnosed with pediatric brain tumor, treated with (n = 12) or without (n = 15) RT, who completed experimental and standardized measures of working memory and attention (n-back and digit span tasks). Children treated with radiation performed less well than those who did not receive radiation on the n-back measure, though performance at the 0-back level was considerably poorer than would be expected for both groups, perhaps suggesting difficulties with more basic processes such as vigilance. Along these lines, marginal differences were noted on digit span forward. The findings are discussed with respect to models of attention and working memory, and the interplay between the two.

Entities:  

Keywords:  Attention; Brain tumor; Pediatric; Radiation therapy; Working memory

Mesh:

Year:  2016        PMID: 27225618      PMCID: PMC5124420          DOI: 10.1080/09297049.2016.1183608

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN: 0929-7049            Impact factor:   2.500


  34 in total

1.  Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ.

Authors:  Donald J Mabbott; Michael D Noseworthy; Eric Bouffet; Conrad Rockel; Suzanne Laughlin
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

2.  Verbal Working Memory Load Affects Regional Brain Activation as Measured by PET.

Authors:  J Jonides; E H Schumacher; E E Smith; E J Lauber; E Awh; S Minoshima; R A Koeppe
Journal:  J Cogn Neurosci       Date:  1997-07       Impact factor: 3.225

3.  The relationship between working memory and cerebral white matter volume in survivors of childhood brain tumors treated with conformal radiation therapy.

Authors:  Lisa M Jacola; Jason M Ashford; Wilburn E Reddick; John O Glass; Robert J Ogg; Thomas E Merchant; Heather M Conklin
Journal:  J Neurooncol       Date:  2014-05-22       Impact factor: 4.130

4.  Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

Authors:  S L Palmer; O Goloubeva; W E Reddick; J O Glass; A Gajjar; L Kun; T E Merchant; R K Mulhern
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

5.  Cognitive mediation of adult age differences in language performance.

Authors:  S T See; E B Ryan
Journal:  Psychol Aging       Date:  1995-09

6.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Authors:  M D Ris; R Packer; J Goldwein; D Jones-Wallace; J M Boyett
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

Review 7.  Long-term neurobehavioral outcome in pediatric brain-tumor patients: review and methodological critique.

Authors:  M D Ris; R B Noll
Journal:  J Clin Exp Neuropsychol       Date:  1994-02       Impact factor: 2.475

8.  Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.

Authors:  Iska Moxon-Emre; Eric Bouffet; Michael D Taylor; Normand Laperriere; Nadia Scantlebury; Nicole Law; Brenda J Spiegler; David Malkin; Laura Janzen; Donald Mabbott
Journal:  J Clin Oncol       Date:  2014-02-10       Impact factor: 44.544

9.  Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study.

Authors:  Shawna L Palmer; Carol Armstrong; Arzu Onar-Thomas; Shengjie Wu; Dana Wallace; Melanie J Bonner; Jane Schreiber; Michelle Swain; Lynn Chapieski; Donald Mabbott; Sarah Knight; Robyn Boyle; Amar Gajjar
Journal:  J Clin Oncol       Date:  2013-08-26       Impact factor: 44.544

10.  Cognitive functioning in long-term survivors of high-grade glioma.

Authors:  Y M Archibald; D Lunn; L A Ruttan; D R Macdonald; R F Del Maestro; H W Barr; J H Pexman; B J Fisher; L E Gaspar; J G Cairncross
Journal:  J Neurosurg       Date:  1994-02       Impact factor: 5.115

View more
  3 in total

1.  Dose-volume metrics and their relation to memory performance in pediatric brain tumor patients: A preliminary study.

Authors:  Kimberly P Raghubar; Michael Lamba; Kim M Cecil; Keith Owen Yeates; E Mark Mahone; Christina Limke; David Grosshans; Travis J Beckwith; M Douglas Ris
Journal:  Pediatr Blood Cancer       Date:  2018-06-01       Impact factor: 3.167

2.  Neurocognitive impairment, employment, and social status in radiotherapy-treated adult survivors of childhood brain tumors.

Authors:  Tiina M Remes; Emma Hovén; Niina Ritari; Heli Pohjasniemi; Riina Puosi; Pekka M Arikoski; Mikko O Arola; Päivi M Lähteenmäki; Tuula R I Lönnqvist; Marja K Ojaniemi; V Pekka Riikonen; Kirsti H Sirkiä; Satu Winqvist; Heikki M J Rantala; Marika Harila; Arja H Harila-Saari
Journal:  Neurooncol Pract       Date:  2021-01-22

3.  Neuropsychological Consequences for Survivors of Childhood Brain Tumor in Malaysia.

Authors:  Hamidah Alias; Sie Chong D Lau; Ilse Schuitema; Leo M J de Sonneville
Journal:  Front Psychol       Date:  2018-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.